Kamada Plans $69M Nasdaq IPO

Israeli pharmaceutical company Kamada Ltd., which is publicly traded on the Tel Aviv Stock Exchange, is planning to raise $69 million on Nasdaq. The funds will be raised in accordance to the companies market cap on the Tel Aviv Stock Exchange, which is $331 million.